AI
CNMD icon

Analytic Investors’s CONMED CNMD Stock Holding History

Analytic Investors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,574
Closed -$696K – 607
2016
Q2 		$696K Sell
14,574
-5,530
-28% -$234K 0.01% 425
2016
Q1 		$843K Sell
20,104
-12,100
-38% -$475K 0.01% 421
2015
Q4 		$1.42M Buy
+32,204
New +$1.4M 0.02% 344

Other funds holding CNMD

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Analytic Investors's CNMD Position: Q3 2016 in Review

Analytic Investors sold out of CONMED (CNMD) in Q3 2016, closing a stake of 14,574 shares — an estimated $696K sold.

Analytic Investors first reported a position in CNMD in Q4 2015 and held it in 3 quarters. The position peaked at $1.42M in Q4 2015. 145 funds tracked by Wall St. Rank hold CNMD as of Q3 2016.

  • Analytic Investors reported no remaining CONMED position as of Q3 2016 after selling out during the quarter.
  • Analytic Investors sold 14,574 CONMED shares in Q3 2016, an estimated $696K.
  • Analytic Investors first reported a position in CONMED in Q4 2015 and held it in 3 quarters.
  • Analytic Investors's CONMED position peaked at $1.42M in Q4 2015.
  • 145 funds tracked by Wall St. Rank held CONMED as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.